Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy
1
Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 4 Święcickiego St., 60-781 Poznan, Poland
2
Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, 49 Przybyszewskiego St., 60-355 Poznan, Poland
*
Author to whom correspondence should be addressed.
Academic Editors: Malgorzata Kloc and Jacek Z. Kubiak
Int. J. Mol. Sci. 2021, 22(16), 8663; https://doi.org/10.3390/ijms22168663
Received: 6 July 2021
/
Revised: 7 August 2021
/
Accepted: 8 August 2021
/
Published: 12 August 2021
(This article belongs to the Special Issue Coronavirus Disease (COVID-19): Pathophysiology)
Recently, we have experienced a serious pandemic. Despite significant technological advances in molecular technologies, it is very challenging to slow down the infection spread. It appeared that due to globalization, SARS-CoV-2 spread easily and adapted to new environments or geographical or weather zones. Additionally, new variants are emerging that show different infection potential and clinical outcomes. On the other hand, we have some experience with other pandemics and some solutions in virus elimination that could be adapted. This is of high importance since, as the latest reports demonstrate, vaccine technology might not follow the new, mutated virus outbreaks. Thus, identification of novel strategies and markers or diagnostic methods is highly necessary. For this reason, we present some of the latest views on SARS-CoV-2/COVID-19 therapeutic strategies and raise a solution based on miRNA. We believe that in the face of the rapidly increasing global situation and based on analogical studies of other viruses, the possibility of using the biological potential of miRNA technology is very promising. It could be used as a promising diagnostic and prognostic factor, as well as a therapeutic target and tool.
View Full-Text
Keywords:
coronavirus; SARS-CoV-2; COVID-19; miRNA; miR; COVID-19 therapy
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Narożna, M.; Rubiś, B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int. J. Mol. Sci. 2021, 22, 8663. https://doi.org/10.3390/ijms22168663
AMA Style
Narożna M, Rubiś B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. International Journal of Molecular Sciences. 2021; 22(16):8663. https://doi.org/10.3390/ijms22168663
Chicago/Turabian StyleNarożna, Maria, and Błażej Rubiś. 2021. "Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy" International Journal of Molecular Sciences 22, no. 16: 8663. https://doi.org/10.3390/ijms22168663
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
